Address & contact
https://www.hhesc.co.il/about-us/Specialties
Reports that name this provider
- Stem Cell Therapy Quality in Israel
- Director Prof. Benjamin Reubinoff; operates FDA and European QMS-compliant Quality Management System; produces GMP-grade, xeno-free, feeder-independent hESC lines; distributed to commercial entities in clinical trials; OpRegen program for dry AMD received FDA Phase 1/2a approval in 2016; partnerships with Lineage Cell Therapeutics and Roche/Genentech